stockrow
Saturday 7 November 2026
Export SRTA’s income statement to Excel — free account
Strata Critical Medical, Inc.
SRTA Healthcare Medical Care Facilities
- Revenue
- +50.3%
- EPS
- −112.3%
- Free cash flow
- +121.3%
Quarter to September 2026, against a year earlier
5.57
0.31
+5.89%
Follow SRTA
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Sep '21 | Dec '20 | Sep '20 | Dec '19 | Sep '19 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 5 | 4 | — | — | — | — | — | — | — |
P/E ratio |
9.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 15.45 | — | 491.50 |
Altman Z-Score |
5.25 | 5.60 | 2.51 | 3.19 | 5.68 | 5.80 | — | 19.91 | — | — |
P/S ratio |
2.00 | 1.72 | 1.11 | 1.65 | 5.04 | 12.00 | — | 0.00 | — | 0.00 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — | 0.00 |
Altman Z″-Score (non-manufacturers) |
6.54 | 7.27 | 4.54 | 7.42 | 10.95 | 10.48 | — | (6.03) | — | — |
P/Operating CF |
(47.53) | (188.00) | (26.90) | (26.45) | (62.93) | (123.94) | — | 8.69 | — | (48,922.50) |
Beneish M-Score |
(0.84) | (2.22) | (2.42) | (1.02) | — | (1.31) | — | — | — | — |
P/B ratio |
1.41 | 1.48 | 1.07 | 0.88 | 1.30 | 2.46 | — | 7.45 | — | 12.72 |
Price to Tangible BV |
2.75 | 1.66 | 1.45 | 1.28 | 1.49 | 2.71 | — | 7.83 | — | 12.72 |
EV/Sales |
1.69 | 1.07 | 0.37 | 0.31 | 1.28 | 6.91 | — | 0.00 | — | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 3.91 | — | 0.00 |
EV/Operating CF |
(6.82) | (81.10) | (2.58) | (1.23) | (4.44) | (25.82) | — | (104.74) | — | 0.00 |
EV/FCF |
(5.56) | (5.75) | (2.43) | (1.20) | (4.34) | (24.82) | — | (104.74) | — | 0.00 |
Quick Ratio |
5.13 | 6.38 | 5.31 | 7.74 | 22.54 | 32.37 | 2.17 | 2.11 | 3.52 | 1,191.20 |
Current Ratio |
6.38 | 7.07 | 5.81 | 8.20 | 23.07 | 32.99 | 2.29 | 2.27 | 3.85 | 1,191.20 |
Net Debt/EBITDA |
4.34 | 7.55 | 2.74 | 4.08 | 8.48 | 12.97 | 1.25 | 1.25 | 4.87 | 24.86 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Asset Turnover |
0.68 | 0.53 | 0.73 | 0.44 | 0.22 | 0.16 | 0.00 | 0.16 | 0.00 | 0.23 |
Operating CF/Net income |
(1.18) | 0.09 | 0.58 | 1.36 | 0.55 | 0.39 | (6.22) | 1.06 | (0.33) | 0.95 |
Capex/Depreciation |
(1.35) | (5.53) | (0.28) | (0.13) | (9.81) | (0.50) | — | (0.72) | — | (1.28) |
| 16.51% | (11.97%) | (22.04%) | (9.63%) | (13.48%) | (27.04%) | 1.59% | (126.37%) | 27.13% | 0.00% | |
| 14.21% | (9.90%) | (18.09%) | (8.25%) | (11.57%) | (12.89%) | 0.09% | (6.88%) | 0.28% | (7.88%) | |
ROIC |
(6.42%) | (14.54%) | (63.53%) | (42.17%) | (246.73%) | 0.00% | (10.21%) | 0.00% | (4.54%) | 0.00% |
Return on Tangible Assets |
28.95% | (16.40%) | (32.29%) | (14.08%) | (13.82%) | (13.05%) | 25.27% | (103.74%) | 74.09% | (3.94%) |
Average Days of Receivables |
73.98 | 49.28 | 34.05 | 27.17 | 26.95 | 27.20 | — | 17.01 | — | 0.00 |
Research and Development Expense of Revenue |
0.00% | 2.17% | 2.05% | 3.79% | 3.18% | 3.00% | — | 3.67% | — | 2.41% |
Selling, General and Administrative Expense of Revenue |
30.88% | 34.64% | 46.90% | 48.08% | 62.15% | 66.07% | 0.00% | 50.46% | — | 49.65% |
Intangible Assets out of Total Assets |
0.42 | 0.09 | 0.21 | 0.26 | 0.11 | 0.08 | 0.00 | 0.03 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
9.05% | 13.55% | 5.55% | 5.66% | 16.70% | 19.04% | — | 2.09% | — | 1.02% |
Graham Net Nets |
0.20 | 0.38 | 0.58 | 0.70 | 0.66 | 0.37 | — | 0.09 | — | 0.08 |
Graham Number |
6.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 4.44 | — | 0.00 |
Earnings Yield |
10.54% | (8.47%) | (22.17%) | (11.54%) | (8.55%) | (13.27%) | — | 6.47% | — | 0.20% |
Free Cash Flow Yield |
(15.18%) | (10.78%) | (13.69%) | (15.72%) | (5.85%) | (2.32%) | — | (0.81%) | — | 0.00% |
Revenue per Share |
2.40 | 1.89 | 3.06 | 2.05 | 1.75 | 1.18 | 0.00 | 0.93 | 0.00 | 1.24 |
Operating CF per Share |
(0.60) | (0.03) | (0.44) | (0.52) | (0.50) | (0.36) | (0.10) | (0.43) | (0.04) | (0.41) |
Capex per Share |
(0.13) | (0.43) | (0.03) | (0.01) | (0.30) | (0.01) | 0.00 | (0.01) | 0.00 | (0.02) |
Free Cash Flow per Share |
(0.73) | (0.46) | (0.47) | (0.53) | (0.80) | (0.37) | (0.10) | (0.44) | (0.04) | (0.43) |
Cash per Share |
0.75 | 1.61 | 2.28 | 2.74 | 6.59 | 7.11 | 0.10 | 0.49 | 0.18 | 10.95 |
Shareholders Equity per Share |
3.40 | 2.86 | 3.19 | 3.85 | 6.79 | 6.79 | 0.61 | 0.44 | 0.70 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3.40 | 2.86 | 3.19 | 3.85 | 6.79 | 6.79 | 0.61 | 0.44 | 0.70 | 0.00 |
Free Cash Flow |
(59.92) | (35.50) | (34.32) | (37.86) | (34.51) | (15.91) | (0.79) | (11.19) | (0.26) | (10.91) |
Working Capital |
106.40 | 138.02 | 170.77 | 191.52 | 282.16 | 304.92 | 0.51 | 8.04 | 1.06 | 274.94 |
Capital Expenditures |
(11.01) | (32.98) | (1.97) | (0.73) | (12.88) | (0.30) | — | (0.38) | — | (0.60) |
Net Current Asset Value |
79.79 | 126.01 | 145.62 | 167.59 | 250.43 | 262.28 | (271.94) | 7.74 | (271.26) | 274.94 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — | 0.00 |
Capex to Sales |
0.06 | 0.22 | 0.01 | 0.01 | 0.17 | 0.01 | — | 0.02 | — | 0.02 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.22 | 0.21 | 2.45 | 2.81 | 0.64 | 0.30 | — | 0.30 | — | 0.00 |
Cash ROIC |
(17.60%) | (10.23%) | (8.55%) | (8.06%) | (6.01%) | (2.67%) | (13.59%) | (47.93%) | (4.07%) | (3.96%) |
Accounts Receivable Turnover |
6.60 | 7.19 | 14.13 | 17.79 | 16.14 | 20.81 | — | 9.65 | — | 0.00 |
Accounts Payable Turnover |
11.00 | 7.09 | 9.06 | 10.81 | 11.22 | 15.21 | — | 8.08 | — | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — | 0.00 |
Average Days of Payables |
44.78 | 28.71 | 47.57 | 48.74 | 38.31 | 40.85 | — | 13.42 | — | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — | 0.00 |
Average Receivables |
29.89 | 20.41 | 15.94 | 8.21 | 4.66 | 2.43 | — | 2.43 | — | — |
Average Payables |
14.18 | 16.54 | 20.20 | 11.45 | 5.41 | 2.61 | — | 2.61 | — | — |
Average Assets |
291.07 | 275.81 | 309.98 | 330.45 | 339.64 | 310.62 | 147.78 | 147.70 | 276.43 | 137.58 |
Average Common Equity |
250.51 | 228.12 | 254.39 | 282.93 | 291.30 | 148.11 | 8.04 | 8.04 | 2.89 | — |
Columns are period end dates · fundamentals updated 5 Nov 2026